EichorEICHOR
Study identifier: NCT07257289 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Recruiting

Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease

Condition: Hereditary Heart Diseases  ·  Sponsor: Nantes University Hospital

PhaseN/A
Planned participants1000
Who can joinAll sexes, 1 Year to 100 Years
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

Sudden cardiac death (SCD) is one of the leading causes of death in developed countries. These deaths (more than 5,000 per year in France) are due to hereditary arrhythmias or cardiomyopathies. Early diagnosis of SCD is often achieved through family screening, but the main challenge is to stratify the risk of SCD in these patients. Indeed, prevention of SCD relies mainly on the implantation of an automatic defibrillator. The challenge is to identify patients who will develop SCD and avoid implanting an implantable cardioverter defibrillator (ICD) in patients who will never develop arrhythmias but who will face complications related to the ICD (inappropriate shocks, infection, lead failure), leading to a reduced quality of life and significant costs for the healthcare system. However, there is a lack of relevant clinical and biological markers for risk stratification, which rules out any possibility of preventive screening. Most of the clinical and ECG (electrocardiogram) parameters identifying an increased risk of SCD have not been reproduced in replication studies. In this project, the investigator will develop a data processing and analysis pipeline using artificial intelligence methods to assess the individual risk of serious arrhythmic events or heart failure in patients with hereditary arrhythmic diseases or cardiomyopathies through the automated processing of multimodal data (clinical data, electrocardiogram (ECG), imaging (echocardiography, MRI magnetic resonance imag…

This description comes directly from the study's public registry record.

Talk to the study team

Vincent Probst, PU-PH  ·  02 40 16 56 99  ·  vincent.probst@chu-nantes.fr

Aurélie Thollet  ·  aurelie.thollet@chu-nantes.fr

Always discuss trial participation with your own doctor first.

Locations (15)

CHU de BordeauxBordeaux, FranceNot Yet Recruiting
CHU de BrestBrest, FranceNot Yet Recruiting
CHU de Clermont-FerrandClermont-Ferrand, FranceNot Yet Recruiting
CHU de DijonDijon, FranceNot Yet Recruiting
CHU de La RochelleLa Rochelle, FranceNot Yet Recruiting
CHU de LimogesLimoges, FranceNot Yet Recruiting
CHU de MontpellierMontpellier, FranceNot Yet Recruiting
CHU de NantesNantes, FranceRecruiting
CHU de PoitiersPoitiers, FranceNot Yet Recruiting
CHU de RennesRennes, FranceNot Yet Recruiting
CHU de StrasbourgStrasbourg, FranceNot Yet Recruiting
CHU de ToulouseToulouse, FranceNot Yet Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →